Kvika banki hf.
A meeting of the Board of Directors of Kvika banki hf. ("Kvika" or "the bank") on 28 January 2021 approved its operating budget for 2021.
Forecast profit for 2021 of ISK 2,600-3,000 million before tax
The budget anticipates a pre-tax profit in the range of ISK 2,600 to 3,000 million.
The Bank's performance may deviate from this forecast, among other things, due to market conditions and other unforeseen events.
A merger with TM hf. and Lykill fjármögnun hf. is anticipated before the end of Q1 2021. Since the approval of supervisory authorities and shareholders of all parties has not yet been obtained the forecast does not include the anticipated financial effects of the merger. Should the merger be approved the change to the forecast will be considerable. A new forecast will be published after the merger is finalised.
Performance above guidance according to preliminary results
According to preliminary results, Kvika's profit in 2020 is expected to be around ISK 2,340 million before tax. The bank's guidance for 2020 was raised in October to an estimated pre-tax profit of ISK 2,000 to 2,300 million.
Kvika’s Board of Directors will propose to a shareholders’ meeting that no dividends be paid in 2021 for the 2020 operating year. This proposal is submitted in view of the proposed merger. The Board of Directors does intend, however, to request that the bank’s Annual General Meeting grant an authorisation for share buy-backs.
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Novo Nordisk A/S17.9.2025 23:05:02 CEST | Press release
Novo Nordisk’s oral semaglutide 25 mg (Wegovy® in a pill*) delivered 16.6% weight loss in people with obesity in a newly published study
Biogen Inc.17.9.2025 22:30:05 CEST | Press release
Biogen Receives European Commission Approval for ZURZUVAE® (zuranolone), the First and Only Treatment Approved for Women with Postpartum Depression in Europe
Atico Mining Corporation17.9.2025 22:30:00 CEST | Press release
Atico Signs the Investment Protection Agreement with Government of Ecuador for its La Plata Project
Frontline plc.17.9.2025 22:06:51 CEST | Press release
FRO – Filing of Half Yearly Report
VCI Global Limited17.9.2025 21:00:00 CEST | Press release
VCI Global Initiates Rescission and Cancellation of Shares from QuantGold Transaction, Tightening Capital Structure Following Reverse Split
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom